Literature DB >> 26898786

[Population colorectal cancer screening in the Czech Republic].

Miroslav Zavoral, Gabriela Vojtěchová, Ondřej Májek, Ondřej Ngo, Tomáš Grega, Bohumil Seifert, Ladislav Dušek, Štěpán Suchánek.   

Abstract

UNLABELLED: Colorectal cancer (CRC) is the third most common malignant disease in developed countries and its incidence is steadily growing. This trend has a stable character despite the fact that CRC is among the best prevention influenced malignancies. National CRC screening program in the Czech Republic, which was established in year 2000, follows the world trends resulting from evidence based medicine. Currently, the basic tools of screening program are immunochemical fecal occult blood tests and colonoscopy in case of their positivity or screening colonoscopy. Stagnation of participating population resulted to initiation of address invitation of the target population in January 2014, in which citizens are regularly invited to attend the screening program and their response is subsequently evaluated. Screening that impacts whole target group is called population screening. KEY WORDS: colorectal cancer, population screening program, colonoscopy, fecal occult blood tests, address invitation.

Entities:  

Mesh:

Year:  2016        PMID: 26898786

Source DB:  PubMed          Journal:  Cas Lek Cesk        ISSN: 0008-7335


  2 in total

Review 1.  Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review.

Authors:  Kristyna Mezerova; Vladislav Raclavsky; Lubomir Stary
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

2.  Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.

Authors:  Radek Kroupa; Monika Ondrackova; Petra Kovalcikova; Milan Dastych; Tomas Pavlik; Lumir Kunovsky; Jiri Dolina
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.